iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/26256124
Adverse reactions to snake antivenom, and their prevention and treatment - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;81(3):446-52.
doi: 10.1111/bcp.12739. Epub 2015 Sep 16.

Adverse reactions to snake antivenom, and their prevention and treatment

Affiliations
Review

Adverse reactions to snake antivenom, and their prevention and treatment

H Asita de Silva et al. Br J Clin Pharmacol. 2016 Mar.

Abstract

Antivenom is the mainstay of treatment of snakebite envenoming. However, adverse reactions to snake antivenom that is available are common in many parts of the world where snakebite is prevalent. Both acute (anaphylactic or pyrogenic) and delayed (serum sickness type) reactions occur. Acute reactions are usually mild but severe systemic anaphylaxis may develop, often within an hour or so of exposure to antivenom. Serum sickness after antivenom has a delayed onset between 5 and 14 days after its administration. Ultimately, the prevention reactions will depend mainly on improving the quality of antivenom. Until these overdue improvements take place, doctors will have to depend on pharmacological prophylaxis, where the search for the best prophylactic agent is still on-going, as well as careful observation of patients receiving antivenom in preparation for prompt management of acute as well as delayed reactions when they occur.

Keywords: acute reactions; antivenom reactions; prophylaxis; serum; snakebite envenoming.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, Savioli L, Lalloo DG, de Silva HJ. Estimation of the global burden of snakebite. PLoS Med 2008; 5: e218. - PMC - PubMed
    1. Chippaux JP. Estimate of the burden of snakebites in sub‐Saharan Africa: a meta‐analytic approach. Toxicon 2011; 57: 586–99. - PubMed
    1. Williams SS, Wijesinghe CA, Jayamanne SF, Buckley NA, Dawson AH, Lalloo DG, de Silva HJ. Delayed psychological morbidity associated with snakebite envenoming. PLoS Negl Trop Dis 2011; 5: e1255. - PMC - PubMed
    1. Chippaux JP. Estimating the global burden of snakebite can help to improve management. PLoS Med 2008; 5: e221. - PMC - PubMed
    1. Gutiérrez JM, Theakston RD, Warrell DA. Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med 2006; 3: e150. - PMC - PubMed

MeSH terms